TBPMQ — Tetra Bio Pharma Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $0.85m
Annual balance sheet for Tetra Bio Pharma, fiscal year end - November 30th, CAD millions except per share, conversion factor applied.
2017 November 30th | 2018 November 30th | 2019 November 30th | 2020 November 30th | 2021 November 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 2.19 | 13.6 | 2.04 | 2.5 | 4.89 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.194 | 0.759 | 0.294 | 0.653 | 0.256 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 2.49 | 14.5 | 5.38 | 3.58 | 5.95 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | — | — | 0.227 | 0.435 | 0.692 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 11.1 | 23.4 | 28.6 | 29.3 | 7.55 |
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.499 | 2.54 | 3.92 | 6.75 | 7.3 |
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Liabilities | -0.024 | 2.54 | 3.92 | 6.75 | 7.3 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 11.2 | 20.9 | 24.7 | 22.6 | 0.249 |
Total Liabilities & Shareholders' Equity | 11.1 | 23.4 | 28.6 | 29.3 | 7.55 |
Total Common Shares Outstanding |